Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Cytogenetic Subgroups Drive Risk Stratification and Response to Chemotherapy and Blinatumomab in Children and Young Adults with Relapsed B-ALL: A Children's Oncology Group Study

Teena Bhatla, MD, Laura Hogan, MD, Xinxin Xu, MS, Lingyun Ji, Andrew J Carroll, PhD, Nyla A Heerema, PhD, Mary Shago, PhD, Lia Gore, MD, James A. Whitlock, MD, Stephen P Hunger, MD, Mignon L. Loh, MD, Patrick A. Brown, MD

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-136364

Published: 2020

Journal Articles

Induction Toxicities Are More Frequent in Young Adults Compared to Children Treated on the Children's Oncology Group (COG) First Relapse B-Lymphoblastic Leukemia Clinical Trial AALL1331

Laura Brook Hogan, MD, Teena Bhatla, MD, Sue Rheingold, MD, Lingyun Ji, PhD, Xinxin Xu, Elizabeth A. Raetz, MD, Stephen P. Hunger, MD, Mignon L. Loh, MD, Patrick Brown, MD

Blood (2018) 132 (Supplement 1): 1382.

https://doi.org/10.1182/blood-2018-99-112269

Published: 2018

Journal Articles

Genomic and Epigenetic Effects of DNA Methyltransferase Inhibition in Acute Lymphoblastic Leukemia

Shella Saint Fleur-Lominy, MDPhD, Teena Bhatla, MD, Stephen Kelly, MS, Varshini Vasudevaraja, MS, Aristotelis Tsirigos, PhD, William L. Carroll, MD

Blood (2017) 130 (Supplement 1): 2479.

https://doi.org/10.1182/blood.V130.Suppl_1.2479.2479

Published: 2017

Journal Articles

Measurement of Phosphorylated ERK As a Prognostic and Predictive Marker for MEK Inhibition in Pediatric B-Lymphoblastic Leukemia: A Pilot Study

Pillai Pallavi Madhusoodhan, MD, Nikki Ann Evensen, PhD BS, Jason Saliba, PhD, Ashfiyah Chowdhury, BS, Daniel Newman, BA, BS, Cristina Delgado-Martin, PhD, Teena Bhatla, MD, Mignon L. Loh, MD, Michelle L. Hermiston, MD PhD, William L. Carroll, MD

Blood (2016) 128 (22): 1739.

https://doi.org/10.1182/blood.V128.22.1739.1739

Published: 2016

Journal Articles

Deciphering the Epigenetic Landscape of Relapsed Pediatric Acute Lymphoblastic Leukemia

Teena Bhatla, MD, Roy Blum, PhD, Jinhua Wang, PhD, Courtney L Jones, PhD, Debra J. Morrison, PhD, Elizabeth A Raetz, MD, Michael J. Burke, MD, Patrick Brown, MD, Richard C. Harvey, PhD, Cheryl L. Willman, MD, Mignon Loh, MD, Stephen P. Hunger, MD, William L. Carroll, MD

Blood (2014) 124 (21): 612.

https://doi.org/10.1182/blood.V124.21.612.612

Published: 2014

Journal Articles

MAPK Signaling Cascades Mediate Distinct Glucocorticoid Resistance Mechanisms in Pediatric B-Precursor ALL

Courtney L Jones, PhD, Christy M Gearheart, PhD, Susan Fosmire, Cristina Delgado-Martin, PhD, Faye Pais, MD, Jinhua Wang, PhD, Teena Bhatla, MD, Danielle S Bitterman, Simone R de Rijk, Wallace Bourgeois, Smita C. Dandekar, MD, Elizabeth A. Raetz, MD, Michelle L. Hermiston, MD PhD, Michael J Garabedian, PhD, Christopher C. Porter, MD, William L. Carroll, MD

Blood (2014) 124 (21): 789.

https://doi.org/10.1182/blood.V124.21.789.789

Published: 2014

Journal Articles

Deletions In TBL1XR1 Results In Glucocorticoid Resistance By Decreasing Glucocorticoid Signaling In Childhood B-Lymphoblastic Leukemia

Courtney L Jones, Teena Bhatla, MD, Jinhua Wang, PhD, Wallace Bourgeois, Bitterman S Danielle, Elizabeth A. Raetz, MD, Debra J. Morrison, PhD, David T. Teachey, MD, Garabedian Michael, William L. Carroll, MD

Blood (2013) 122 (21): 602.

https://doi.org/10.1182/blood.V122.21.602.602

Published: 2013

Journal Articles

Genome-Wide shRNA Screen Implicates Mitogen Activated Protein Kinase (MAPK) Pathway In Glucocorticoid Resistance In Acute Lymphoblastic Leukemia

Jones L. Courtney, Christy M. Gearheart, Ph.D., Fosmire Susan, Wang Jinhua, Ph.D., Danielle S. Bitterman, Teena Bhatla, MD, Wallace Bourgeois, Christopher C. Porter, MD, William L. Carroll, MD

Blood (2013) 122 (21): 1296.

https://doi.org/10.1182/blood.V122.21.1296.1296

Published: 2013

Journal Articles

Inhibition Of The Wnt Pathway Leads To Improved Chemosensitivity In Pediatric Acute Lymphoblastic Leukemia

Smita C. Dandekar, MD, Eleny Romanos-Sirakis, MD, Faye Pais, Ph.D., Teena Bhatla, MD, Courtney L Jones, Wallace Bourgeois, Stephen P. Hunger, MD, Elizabeth A. Raetz, MD, Michelle L. Hermiston, MD, PhD, Ramanuj Dasgupta, Debra J. Morrison, PhD, William L. Carroll, MD

Blood (2013) 122 (21): 1428.

https://doi.org/10.1182/blood.V122.21.1428.1428

Published: 2013

Journal Articles

Epigenetic Modulation Leads to Re-Expression of Relapse Specific Silenced Genes and Induces Chemosensitivity in Childhood Acute Lymphoblastic Leukemia (ALL),

Teena Bhatla, MD, Debra J. Morrison, PhD, Jinhua Wang, PhD, Elizabeth A. Raetz, MD, Michael Burke, MD, Patrick Brown, MD, William L. Carroll, MD

Blood (2011) 118 (21): 3455.

https://doi.org/10.1182/blood.V118.21.3455.3455

Published: 2011

Journal Articles

Vorinostat Reverses Relapse-Specific Drug Resistance Gene Expression Signatures In Childhood Acute Lymphoblastic Leukemia (ALL).

Teena Bhatla, MD, Jinhua Wang, PhD, Debra J. Morrison, PhD, Wafik T. Zaky, MD, Elizabeth A. Raetz, MD, William L. Carroll, MD

Blood (2010) 116 (21): 3630.

https://doi.org/10.1182/blood.V116.21.3630.3630

Published: 2010

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Cytogenetic Subgroups Drive Risk Stratification and Response to Chemotherapy and Blinatumomab in Children and Young Adults with Relapsed B-ALL: A Children's Oncology Group Study

Induction Toxicities Are More Frequent in Young Adults Compared to Children Treated on the Children's Oncology Group (COG) First Relapse B-Lymphoblastic Leukemia Clinical Trial AALL1331

Genomic and Epigenetic Effects of DNA Methyltransferase Inhibition in Acute Lymphoblastic Leukemia

Measurement of Phosphorylated ERK As a Prognostic and Predictive Marker for MEK Inhibition in Pediatric B-Lymphoblastic Leukemia: A Pilot Study

Deciphering the Epigenetic Landscape of Relapsed Pediatric Acute Lymphoblastic Leukemia

MAPK Signaling Cascades Mediate Distinct Glucocorticoid Resistance Mechanisms in Pediatric B-Precursor ALL

Deletions In TBL1XR1 Results In Glucocorticoid Resistance By Decreasing Glucocorticoid Signaling In Childhood B-Lymphoblastic Leukemia

Genome-Wide shRNA Screen Implicates Mitogen Activated Protein Kinase (MAPK) Pathway In Glucocorticoid Resistance In Acute Lymphoblastic Leukemia

Inhibition Of The Wnt Pathway Leads To Improved Chemosensitivity In Pediatric Acute Lymphoblastic Leukemia

Epigenetic Modulation Leads to Re-Expression of Relapse Specific Silenced Genes and Induces Chemosensitivity in Childhood Acute Lymphoblastic Leukemia (ALL),

Vorinostat Reverses Relapse-Specific Drug Resistance Gene Expression Signatures In Childhood Acute Lymphoblastic Leukemia (ALL).

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only